Viewing Study NCT01983761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-14 @ 8:16 PM
Study NCT ID: NCT01983761
Status: UNKNOWN
Last Update Posted: 2013-11-18
First Post: 2013-11-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
Sponsor: Targazyme, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Blood And Marrow Transplantation View
None Leukemia View
None Lymphoma View
None Transplantation Infection View
None Myelodysplastic Syndrome (MDS) View
None Non-Hodgkin's Lymphoma (NHL) View
None Hodgkin's Lymphoma View
Keywords: